1 L.D. 1100
2 Date: (Filing No. S- )
3 HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES
4 Reproduced and distributed under the direction of the Secretary of the Senate.
5 STATE OF MAINE
6 SENATE
7 132ND LEGISLATURE
8 FIRST SPECIAL SESSION
9 COMMITTEE AMENDMENT “ ” to S.P. 460, L.D. 1100, “An Act to Clarify the
10 Requirements for Accessing Nonformulary Drugs and Drugs Used to Treat Serious Mental
11 Illness”
12 Amend the bill in section 1 in subsection 2-C in the 6th line (page 1, line 9 in L.D.) by
13 inserting after the following: "unavailable" the following: 'and there is no equivalent
14 formulary drug available'
15 Amend the bill in section 1 in subsection 2-C in the 7th line (page 1, line 10 in L.D.)
16 by striking out the following: "drug for" and inserting the following: 'drug prescribed to
17 assess and treat the enrollee's serious mental illness for'
18 Amend the bill in section 1 in subsection 2-C in the 7th line (page 1, line 10 in L.D.)
19 by striking out the following: "that the" and inserting the following: 'that a'
20 Amend the bill by relettering or renumbering any nonconsecutive Part letter or section
21 number to read consecutively.
22 SUMMARY
2233 This amendment clarifies that a carrier must approve a prior authorization for an
2244 equivalent nonformulary drug that has been prescribed for the treatment of an enrollee's
2255 serious mental illness if there is a shortage of the formulary drug and there is no equivalent
2266 drug available on the carrier's formulary.
2277 FISCAL NOTE REQUIRED
2288 (See attached)
Page 1 - 132LR0629(02)
COMMITTEE AMENDMENT

[DELETED: LD:(RC0R1I2A3i a t f " t f ' t i n e4f5A6b7a8A9b0A1n3T a c t a c m a a p a f a4e5s6d7F8(]